Innate immune memory in cardiometabolic disease
Abstract. Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic cardiovascular disease (CVD), and long-term activation of mye
Abstract. Low-grade systemic inflammation is a key pathophysiological component of atherosclerotic cardiovascular disease (CVD), and long-term activation of mye
By learning and sharing the F.A.S.T. and R.Á.P.I.D.O. warning signs, you just might save a life from stroke. Plus, other symptoms. Prepare yourself and loved…
Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their…
BackgroundSubclinical myocardial injury expressed as higher cardiac troponin concentrations may represent an important intermediary between hypertension and the risk of cardiovascular disease. The …
In this episode, Dr Bret Wiechmann, interventional radiologist and president of the OEIS joins Dr Fadi Saab, interventional cardiologist, to talk about the OEIS and…
May 8, 2024—Reflow Medical, Inc. announced the completion of enrollment in the DEEPER REVEAL clinical trial of the Reflow Spur stent. Accordi
Started in 1946, the Journal of the History of Medicine and Allied Sciences (JHMAS) is internationally recognized as one of the top publications in its…
ACC Accreditation Services 2400 N. St. NW Washington, DC 20037 Please note address change for ACC Accreditation Services Through our Heart Failure Accreditation program, ACC…
BACKGROUND: Echocardiographic (2-dimensional echocardiography) thresholds indicating disease or impaired functional status compared with normal physiological aging in individuals aged ≥65 years are n